Spruce Street Capital LP
CIK 2050194
13F filing for Q2 2026・No. 3,852
- Holdings
- US$509.68M
- Quarter change
- +US$93.75M
- Entries
- 30
- Net bought (estimate)
- +US$17.33M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 5
- Sold out 3
- Cut 1
- Added 8
- Corporate actions 0
- Unchanged 16
Largest holdings
30 stocks worth US$509.68M, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| KINIKSA PHARMACEUTICALS INTLORD SHS CL A | Added | 918,070 | US$58.71M | 11.52% |
| RLAYRELAY THERAPEUTICS INCCOM | Unchanged | 2,984,125 | US$55.83M | 10.95% |
| LB PHARMACEUTICALS INCCOM SHS | Unchanged | 1,376,159 | US$44.66M | 8.76% |
| RELMADA THERAPEUTICS INCCOM | Added | 6,391,328 | US$44.23M | 8.68% |
| ALTO NEUROSCIENCE INCCOM SHS | Added | 1,353,047 | US$35.71M | 7.01% |
| DIANTHUS THERAPEUTICS INCCOM | Cut | 354,816 | US$34.59M | 6.79% |
| ALKSALKERMES PLCSHS | Added | 543,876 | US$28.5M | 5.59% |
| SAVARA INCCOM | Added | 3,452,576 | US$21.27M | 4.17% |
| PCVXVAXCYTE INCCOM | Added | 306,047 | US$17.79M | 3.49% |
| ELVNENLIVEN THERAPEUTICS INCCOM | Unchanged | 329,006 | US$16.7M | 3.28% |
Sign in (free) to see its 30 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 13, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.